• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result
  • Login
  • Register
SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Register
    • Sign-In
    • Manage Subscriptions
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Register
    • Sign-In
    • Manage Subscriptions
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Exemestane plus etinostat does not improve survival compared to exemestane alone for HR⁺ advanced breast cancer

byTeddy Guo
November 8, 2021
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

RELATED REPORTS

#VisualAbstract: Gonadotrophin-releasing hormone analogs reduces rates of premature ovarian insufficiency in premenopausal women with breast cancer

Gonadotropin-releasing hormone analogs protect against premature ovarian insufficiency in breast-cancer patients treated with chemotherapy

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

Click to read this study in the Journal of Clinical Oncology. 

Tags: advanced breast cancerBreast Cancerbreast cancer survivaletinostatexemestanehormone receptor-positive breast canceroncology
Previous Post

Hormonal fluctuations in the menstrual cycle may affect sleep and memory performance

 Next Post

Physical activity is associated with a reduction in all-cause mortality in patients with newly diagnosed Parkinson Disease

RelatedReports

#VisualAbstract: Gonadotrophin-releasing hormone analogs reduces rates of premature ovarian insufficiency in premenopausal women with breast cancer
StudyGraphics

#VisualAbstract: Gonadotrophin-releasing hormone analogs reduces rates of premature ovarian insufficiency in premenopausal women with breast cancer

January 18, 2022
Patient Basics: Female Infertility
Oncology

Gonadotropin-releasing hormone analogs protect against premature ovarian insufficiency in breast-cancer patients treated with chemotherapy

January 10, 2022
#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma
StudyGraphics

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

December 31, 2021
Patient Basics: Breast Cancer
Oncology

Adjuvant chemotherapy may potentially be avoided in breast cancer patients with lymph node-positive disease

December 28, 2021
Next Post
Adolescents’ muscle strength associated with lower cardiometabolic risk

Physical activity is associated with a reduction in all-cause mortality in patients with newly diagnosed Parkinson Disease

Antiarrhythmic drugs have no survival benefit in shock-refractory out-of-hospital cardiac arrest

Similar clinical outcomes for targeted temperature management at 31C versus 34C in cardiac arrest survivors

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

Prescription of tramadol is associated with higher rates of adverse clinical outcomes compared to codeine in patients with chronic, noncancer pain

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get Full Access

Register now to get free full access to over 8000 searchable archived reports, visual abstracts, Classics Series landmark trials, weekly rewinds, and much more.

SUBSCRIBE
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Patients with image-confirmed cerebral infarct have superior benefit from clopidogrel-aspirin therapy in preventing recurrent stroke
  • Rate of adverse events in placebo arms of COVID-19 vaccine trials
  • #VisualAbstract: Nedaplatin-based concurrent chemoradiotherapy is noninferior to cisplatin for stage II-IVB nasopharyngeal carcinoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Register
    • Sign-In
    • Manage Subscriptions

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In